Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Ryota Sueki"'
Autor:
Yuichiro Kemmoto, Shun‐ichiro Ozawa, Ryota Sueki, Keiichi Furuya, Daimon Shirose, Satoshi Wakao, Kuniaki Shindo, Atsushi Nagata, Tadashi Sato
Publikováno v:
DEN Open, Vol 4, Iss 1, Pp n/a-n/a (2024)
Abstract Objectives The utility of texture and color enhancement imaging (TXI) in detecting gastric cancer (GC) has been investigated. However, few reports exist on TXI mode2 (TXI2) used for detecting GC; this study investigated the efficacy of TXI2
Externí odkaz:
https://doaj.org/article/c4875742d40c4c018f756200078b25af
Autor:
Makoto Kadokura, Shinya Maekawa, Ryota Sueki, Mika Miura, Kazuki Komase, Hiroko Shindo, Fumitake Amemiya, Tomoyoshi Uetake, Taisuke Inoue, Minoru Sakamoto, Mina Nakagawa, Naoya Sakamoto, Mamoru Watanabe, Nobuyuki Enomoto
Publikováno v:
PLoS ONE, Vol 6, Iss 9, p e24514 (2011)
BACKGROUND AND AIMS: Patients infected with genotype 2b hepatitis C virus (HCV) generally can achieve favorable responses to pegylated-interferon plus ribavirin therapy (PEG-IFN/RBV). However, a proportion of patients show poorer responses and the co
Externí odkaz:
https://doaj.org/article/fc0bfe67e3e1452e81ee97182e561ff6
Autor:
Yasuhiro Nakayama, Kazuki Komase, Shinya Maekawa, Mika Miura, Minoru Sakamoto, Fumitake Amemiya, Kohji Moriishi, Kuniaki Shindo, Hiroko Shindo, Nobuyuki Enomoto, Makoto Kadokura, Taisuke Inoue, Atsuya Yamashita, Ryota Sueki
Publikováno v:
Hepatology Research. 43:865-875
Aim Prediction of treatment responses to pegylated interferon (PEG IFN) plus ribavirin (RBV) therapy is uncertain for genotype 1b chronic hepatitis C. Methods In this study, 96 patients were investigated for the correlation between 36 pretreatment se
Autor:
Kohji Moriishi, Makoto Kadokura, Nobutoshi Komatsu, Minoru Sakamoto, Mika Miura, Nobuyuki Enomoto, Yasuhiro Nakayama, Kazuki Komase, Atsuya Yamashita, Shinya Maekawa, Taisuke Inoue, Fumitake Amemiya, Ryota Sueki, Kuniaki Shindo, Hiroko Shindo
Publikováno v:
Journal of Viral Hepatitis. 20:281-289
Summary Genetic variation in the IL-28B (interleukin-28B; interferon lambda 3) region has been associated with sustained virological response (SVR) rates in patients with chronic hepatitis C treated with peginterferon-α and ribavirin. However, the m
Autor:
Taisuke Inoue, Hiroko Shindo, Takako Ohmori, Mika Miura, Yasuhiro Nakayama, Minoru Sakamoto, Nobuyuki Enomoto, Ryota Sueki, Asuka Kanayama, Kazuki Komase, Shinya Maekawa, Tomoyoshi Uetake, Fumitake Amemiya, Makoto Kadokura, Kuniaki Shindo
Publikováno v:
Journal of Medical Virology. 84:1360-1368
The emergence of amino acid or nucleotide substitutions leads to lamivudine resistance in hepatitis B virus (HBV) infected patients. The aim of this study was to investigate whether viral sequences help predict the emergence of lamivudine resistance.
Autor:
Taisuke Inoue, Shinya Maekawa, Fumitake Amemiya, Masao Honda, Namiki Izumi, Shuichi Kaneko, Yasuhiro Nakayama, Ryota Sueki, Makoto Kadokura, Nobuyuki Enomoto, Yasuhiro Asahina, Kazuki Komase, Shunichi Okada, Hiroko Shindo, Takatoshi Kitamura, Kuniaki Shindo, Minoru Sakamoto, Mika Miura
Publikováno v:
Hepatology International. 6:482-490
Protease inhibitor (PI)-resistant hepatitis C virus (HCV) variants may be present in substantial numbers in PI-untreated patients according to recent reports. However, influence of these viruses in the clinical course of chronic hepatitis C has not b
Autor:
Mika Miura, Mina Nakagawa, Naoya Sakamoto, Makoto Kadokura, Minoru Sakamoto, Shinya Maekawa, Kazuki Komase, Hiroko Shindo, Nobuyuki Enomoto, Mamoru Watanabe, Tomoyoshi Uetake, Ryota Sueki, Taisuke Inoue, Fumitake Amemiya
Publikováno v:
Hepatology International. 5:789-799
A proportion of patients infected with genotype 2a hepatitis C virus (HCV) cannot achieve a sustained virological response (SVR) to pegylated-interferon plus ribavirin therapy (PEG-IFN/RBV) but the reason remains unclear. The present study aimed to c
Autor:
Kazuki, Komase, Shinya, Maekawa, Mika, Miura, Ryota, Sueki, Makoto, Kadokura, Hiroko, Shindo, Kuniaki, Shindo, Fumitake, Amemiya, Yasuhiro, Nakayama, Taisuke, Inoue, Minoru, Sakamoto, Atsuya, Yamashita, Kohji, Moriishi, Nobuyuki, Enomoto
Publikováno v:
Hepatology research : the official journal of the Japan Society of Hepatology. 43(8)
Prediction of treatment responses to pegylated interferon (PEG IFN) plus ribavirin (RBV) therapy is uncertain for genotype 1b chronic hepatitis C.In this study, 96 patients were investigated for the correlation between 36 pretreatment serum chemokine
Autor:
Takako Ohmori, Minoru Sakamoto, Mika Miura, Nobuyuki Enomoto, Kuniaki Shindo, Shinya Maekawa, Taisuke Inoue, Fumitake Amemiya, Yasuhiro Nakayama, Takatoshi Kitamura, Kazuki Komase, Hiroko Shindo, Tomoyoshi Uetake, Shunichi Okada, Asuka Kanayama, Ryota Sueki, Makoto Kadokura
Publikováno v:
Hepatology international. 6(1)
The association between hepatitis C virus (HCV) sequences with interleukin 28B (IL28B) single-nucleotide polymorphism (SNP) in the development of hepatocellular carcinoma (HCC) has not been well clarified. Complete HCV open-reading frame sequences we
Autor:
Taisuke Inoue, Shinya Maekawa, Kazuki Komase, Nobuyuki Enomoto, Tomoyoshi Uetake, Makoto Kadokura, Mina Nakagawa, Mika Miura, Fumitake Amemiya, Ryota Sueki, Hiroko Shindo, Mamoru Watanabe, Naoya Sakamoto, Minoru Sakamoto
Publikováno v:
PLoS ONE, Vol 6, Iss 9, p e24514 (2011)
PLoS ONE
PLoS ONE
Background and Aims Patients infected with genotype 2b hepatitis C virus (HCV) generally can achieve favorable responses to pegylated-interferon plus ribavirin therapy (PEG-IFN/RBV). However, a proportion of patients show poorer responses and the cor